Active substance
Magaldrate
- SFDA 3
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| ACICONE 540MG-5ML SUSP | 108 mg/ml | Suspension · Oral use | 1 Bottle | SAR 4.95 | Generic · OTC | MEDICAL UNION PHARMACEUTICALS CO | Valid |
| ANTACID JEDCO 480MG CHEWABLE TABLETS | 480 mg | Chewable tablet · Oral use | 20 Blister | SAR 4.45 | Generic · OTC | JEDCO INTERNATIONAL PHARMACEUTICAL | Suspended |
| ACICONE 720 MG CHEWABLE TAB | 720 mg | Chewable tablet · Oral use | 20 Blister | SAR 5.55 | Generic · OTC | MEDICAL UNION PHARMACEUTICALS CO | Invalid · Not Marketed |
Indications — CHI Daman Drug Formulary
TUBERCULOSIS-SUPPORTIVE CARE
Combinations containing Magaldrate
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.